Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -12.22%3.62B | -24.49%3.49B | -51.86%2.4B | 11.77%17.21B | -30.68%3.48B | 67.78%4.12B | 30.56%4.62B | 13.81%4.99B | -27.16%15.4B | 17.71%5.02B |
| Cost of revenue | -20.72%3.47B | -27.87%3.46B | -48.05%2.47B | 9.47%17.01B | -39.72%3.18B | 88.16%4.38B | 34.96%4.79B | 6.04%4.75B | -26.31%15.54B | 7.41%5.28B |
| Gross profit | 156.88%146.28M | 121.65%36.04M | -128.30%-67.05M | 236.68%196.72M | 213.11%296.14M | -298.80%-257.2M | -1,983.38%-166.48M | 342.77%236.91M | -398.33%-143.93M | 59.88%-261.81M |
| Operating expense | 171.16%89M | 25,649.55%84.57M | -65.71%70.37M | -16.37%386.44M | 604.66%256.61M | -227.72%-125.07M | -100.53%-331K | 223.95%205.24M | 8.07%462.05M | 71.78%-50.85M |
| Selling and administrative expenses | -2.05%17.41M | -0.96%19.09M | -6.43%16.37M | 2.03%67.46M | -24.90%12.91M | 23.90%17.78M | -11.04%19.27M | 35.55%17.49M | -13.05%66.11M | 31.48%17.19M |
| -General and administrative expense | -2.05%17.41M | -0.96%19.09M | -6.43%16.37M | 2.03%67.46M | -24.90%12.91M | 23.90%17.78M | -11.04%19.27M | 35.55%17.49M | -13.05%66.11M | 31.48%17.19M |
| Depreciation and amortization | 12.57%42.55M | 13.46%42.79M | 11.69%42.61M | 5.63%152.01M | -1.22%38.34M | 9.21%37.8M | 5.00%37.72M | 10.39%38.15M | --143.91M | --38.82M |
| -Depreciation | 12.57%42.55M | 13.46%42.79M | 11.69%42.61M | 5.63%152.01M | -1.22%38.34M | 9.21%37.8M | 5.00%37.72M | 10.39%38.15M | --143.91M | --38.82M |
| Other operating expenses | -6.66%42.09M | 139.58%22.69M | -92.38%11.4M | -34.29%172.09M | 389.21%205.35M | -25.15%45.1M | -1,167.00%-57.32M | 841.24%149.6M | -25.50%261.9M | 137.29%41.98M |
| Total other operating income | -94.22%13.06M | ---- | ---- | -48.14%5.11M | ---- | 1,900.23%225.75M | ---- | ---- | --9.86M | --148.84M |
| Operating profit | 143.35%57.28M | 70.79%-48.53M | -533.90%-137.42M | 68.69%-189.71M | 118.74%39.53M | -520.13%-132.13M | -134.20%-166.15M | 119.68%31.67M | -59.76%-605.98M | 55.34%-210.97M |
| Net non-operating interest income (expenses) | -4.83%-37.99M | -3.66%-36.88M | -4.72%-34.65M | -32.58%-130.48M | -2.20%-35.75M | -49.14%-36.24M | -28.58%-35.58M | -22.94%-33.09M | -176.32%-98.42M | -740.00%-34.99M |
| Non-operating interest income | ---- | ---- | ---- | -34.10%10.19M | ---- | ---- | ---- | ---- | -24.50%15.46M | ---- |
| Non-operating interest expense | 4.83%37.99M | 3.66%36.88M | 4.72%34.65M | 23.53%140.67M | 2.20%35.75M | 49.14%36.24M | 28.58%35.58M | 22.94%33.09M | 103.03%113.88M | 42.01%34.99M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | -118.28%-37.37M | 204.44M | ||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | -46.51%1.75M | -28.54%1.46M | -41.42%1.63M | -59.77%10.19M | -12.32%2.1M | -73.99%3.27M | -34.51%2.04M | -61.61%2.78M | 29.24%25.32M | 133.28%2.39M |
| Income before tax | 112.74%21.04M | 57.96%-83.96M | -12,632.72%-170.45M | 28.48%-357.56M | 102.41%5.88M | -937.28%-165.1M | -109.09%-199.7M | 100.75%1.36M | -26.77%-499.96M | 49.55%-243.56M |
| Income tax | 0 | 51,812.50%99.29M | 0 | 0 | 0 | 0 | -192K | 100.32%192K | 95.19%-11.39M | 112.40%31.09M |
| Net income | 112.74%21.04M | 8.15%-183.24M | -14,692.89%-170.45M | 26.81%-357.56M | 102.14%5.88M | -7,858.60%-165.1M | -108.89%-199.5M | 100.97%1.17M | -209.93%-488.57M | -18.33%-274.65M |
| Net income continuous operations | 112.74%21.04M | 8.15%-183.24M | -14,692.89%-170.45M | 26.81%-357.56M | 102.14%5.88M | -7,858.60%-165.1M | -108.89%-199.5M | 100.97%1.17M | -209.93%-488.57M | -18.33%-274.65M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 112.74%21.04M | 8.15%-183.24M | -14,692.89%-170.45M | 26.81%-357.56M | 102.14%5.88M | -7,858.60%-165.1M | -108.89%-199.5M | 100.97%1.17M | -209.93%-488.57M | -18.33%-274.65M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 112.74%21.04M | 8.15%-183.24M | -14,692.89%-170.45M | 26.81%-357.56M | 102.14%5.88M | -7,858.60%-165.1M | -108.89%-199.5M | 100.97%1.17M | -209.93%-488.57M | -18.33%-274.65M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 112.74%0.054 | 8.15%-0.5181 | -246.16%-0.0048 | 26.99%-1.0094 | 102.14%0.0166 | -7,141.22%-0.424 | -108.86%-0.5641 | 100.97%0.0033 | -207.55%-1.3826 | -17.64%-0.7765 |
| Diluted earnings per share | 112.74%0.054 | 8.15%-0.5181 | -246.16%-0.0048 | 26.99%-1.0094 | 102.14%0.0166 | -7,141.22%-0.424 | -108.86%-0.5641 | 100.97%0.0033 | -207.55%-1.3826 | -17.64%-0.7765 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.